This inventor holds 1 USPTO granted patent. Top assignee: Hefei Knature Bio-Pharm Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Feng Tian in Genetic Engineering
Introduction
Feng Tian is a prominent inventor based in Anhui, China. He has made significant contributions to the field of genetic engineering, particularly in the development of genetically engineered bacteria. His work focuses on enhancing the production of nicotinamide adenine dinucleotide (NAD), a crucial coenzyme in cellular metabolism.
Latest Patents
Feng Tian holds a patent for a genetically engineered bacterium, its construction method, and its application in producing NAD. The invention details a genetically engineered bacterium where the gene encoding adenine deaminase is knocked out, and the gene encoding the enzyme in the NAD anabolic pathway is integrated into the bacterium's genome. This innovative approach allows for the creation of a strain with high NAD yield, significantly improving the efficiency of NAD production.
Career Highlights
Feng Tian is associated with Hefei Knature Bio-pharm Co., Ltd., where he continues to advance his research in biotechnology. His work has garnered attention for its potential applications in pharmaceuticals and metabolic engineering. With a focus on practical applications, he aims to contribute to the development of sustainable biotechnological solutions.
Collaborations
Feng Tian collaborates with notable colleagues, including Wei Wang and Kanglin Wang. Their combined expertise enhances the research and development efforts at Hefei Knature Bio-pharm Co., Ltd.
Conclusion
Feng Tian's innovative work in genetic engineering exemplifies the potential of biotechnology to address critical challenges in health and industry. His patented methods for producing NAD through genetically engineered bacteria represent a significant advancement in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile